GNL Gut and Liver
  1. Goh Eun Chung, Su-Min Jeong, Eun Ju Cho, Jeong-Ju Yoo, Yuri Cho, Kyu Na Lee, Dong Wook Shin, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Su Jong Yu. Association of fatty liver index with all-cause and disease-specific mortality: A nationwide cohort study. Metabolism 2022;133:155222
    https://doi.org/10.1016/j.metabol.2022.155222
  2. Peng Yu, Zhen Qian, Hongmei Yang, Tianyang Xu, Yulin Dai, Laihui Song, Jinling Liang, Yuying Shi, Zhiguo Zhang, Lijing Li. Icaritin, a metabolite of Icarrin, Alleviates non-alcoholic fatty liver disease via inhibition of lipogenesis and ER stress. European Journal of Pharmacology 2022;937:175378
    https://doi.org/10.1016/j.ejphar.2022.175378
  3. Arefe Nemati, Zeinab Nikniaz, Ali Mota. Effects of Resveratrol Supplementation on Nonalcoholic Fatty Liver Disease Management. 2023;38:144
    https://doi.org/10.1097/TIN.0000000000000314
  4. Asieh Mansour, Saeed Pourhassan, Hadis Gerami, Mohammad Reza Mohajeri‐Tehrani, Marziye Salahshour, Ali Abbasi, Elham Madreseh, Sayed Mahmoud Sajjadi‐Jazi. Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes. Obesity Science & Practice 2024;10
    https://doi.org/10.1002/osp4.777
  5. Hong Jun Yang, Yeon Pyo Hong, Tai-Young Yoon, Jae-Hong Ryoo, Joong-Myung Choi, Chang-Mo Oh. Independent and Synergistic Associations of Aerobic Physical Activity and Resistance Exercise with Nonalcoholic Fatty Liver Disease. Gut and Liver 2023;17:600
    https://doi.org/10.5009/gnl220345
  6. Sue Shea, Christos Lionis, Chris Kite, Lou Atkinson, Lukasz Lagojda, Surinderjeet S. Chaggar, Ioannis Kyrou, Harpal S. Randeva. Challenges in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD): Towards a Compassionate Approach. Livers 2023;3:434
    https://doi.org/10.3390/livers3030031
  7. Peter Konyn, Aijaz Ahmed, Donghee Kim. Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease. Clin Mol Hepatol 2023;29:S43
    https://doi.org/10.3350/cmh.2022.0351
  8. Shengjie Wang, Xianpeng Zeng, Yunying Yang, Shiyi Li, Yanfeng Wang, Qifa Ye, Xiaoli Fan. Hypothermic oxygenated perfusion ameliorates ischemia‐reperfusion injury of fatty liver in mice via Brg1/Nrf2/HO‐1 axis. Artificial Organs 2022;46:229
    https://doi.org/10.1111/aor.14076
  9. Luka Vranić, Anja Radovan, Goran Poropat, Ivana Mikolašević, Sandra Milić. Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time. Medicina 2021;57:1057
    https://doi.org/10.3390/medicina57101057
  10. Varenka Barbero-Becerra, Eva Juárez-Hernández, Norberto C Chávez-Tapia, Misael Uribe. Inulin as a Clinical Therapeutic Intervention in Metabolic Associated Fatty Liver Disease. Food Reviews International 2022;38:336
    https://doi.org/10.1080/87559129.2020.1867997
  11. Sven H Loosen, Münevver Demir, Anselm Kunstein, Markus Jördens, Natalia Qvarskhava, Mark Luedde, Tom Luedde, Christoph Roderburg, Karel Kostev. Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes. BMJ Open Diab Res Care 2021;9:e002243
    https://doi.org/10.1136/bmjdrc-2021-002243
  12. Jun Cao, Lin Hua, Shipei Zhang, Jinping Tang, Fan Ke, Zhouhuan Wu, Guohui Xue. Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease. Lipids Health Dis 2022;21
    https://doi.org/10.1186/s12944-022-01676-0
  13. Donghee Kim, Richie Manikat, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed. Estimated pulse wave velocity in metabolic dysfunction‐associated steatotic liver disease and all‐cause/cause‐specific mortality. J of Gastro and Hepatol 2024;39:1950
    https://doi.org/10.1111/jgh.16608
  14. Yuanyue Zhu, Long Wang, Lin Lin, Yanan Huo, Qin Wan, Yingfen Qin, Ruying Hu, Lixin Shi, Qing Su, Xuefeng Yu, Li Yan, Guijun Qin, Xulei Tang, Gang Chen, Shuangyuan Wang, Hong Lin, Xueyan Wu, Chunyan Hu, Mian Li, Min Xu, Yu Xu, Tiange Wang, Zhiyun Zhao, Zhengnan Gao, Guixia Wang, Feixia Shen, Xuejiang Gu, Zuojie Luo, Li Chen, Qiang Li, Zhen Ye, Yinfei Zhang, Chao Liu, Youmin Wang, Shengli Wu, Tao Yang, Huacong Deng, Lulu Chen, Tianshu Zeng, Jiajun Zhao, Yiming Mu, Weiqing Wang, Guang Ning, Yufang Bi, Yuhong Chen, Jieli Lu. The Association between Educational Attainment and the Risk of Nonalcoholic Fatty Liver Disease among Chinese Adults: Findings from the REACTION Study. Gut and Liver 2024;18:719
    https://doi.org/10.5009/gnl230220
  15. Donghee Kim, Brittany B. Dennis, George Cholankeril, Aijaz Ahmed. Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis. Journal of Affective Disorders 2023;329:184
    https://doi.org/10.1016/j.jad.2023.02.101
  16. M. Elizabeth Sobhia, Sonia Kumari, Harish Kumar, Akshata Gandhe, Dhriti Kaushik, Harish Kumar, Jethender Jain, Ankita, Moyim Mallick, Bommana Pavani, Mridula Moudgil, Deepesh Patel. Emerging Therapies and Therapeutic Targets for Composite Liver Disease: NASH. CTMC 2023;23:2027
    https://doi.org/10.2174/1568026623666230714113808
  17. Ali Mahmoudi, Alexandra E. Butler, Muhammed Majeed, Maciej Banach, Amirhossein Sahebkar. Investigation of the Effect of Curcumin on Protein Targets in NAFLD Using Bioinformatic Analysis. Nutrients 2022;14:1331
    https://doi.org/10.3390/nu14071331
  18. Yuanchen Zhou, Shaojie Duan, Rongrui Wang, Jialiang Chen, Shukun Yao. Nonlinear correlation between fatty liver index and carotid intima media thickness among individuals undergoing health examination. Front. Endocrinol. 2023;14
    https://doi.org/10.3389/fendo.2023.1120581
  19. Brandon J. Perumpail, Richie Manikat, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed, Donghee Kim. The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults. J. pediatr. gastroenterol. nutr. 2024;79:110
    https://doi.org/10.1002/jpn3.12219
  20. Runzhi Yu, Yiqin Huang, Xiaona Hu, Jie Chen. Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis. Heliyon 2024;10:e32783
    https://doi.org/10.1016/j.heliyon.2024.e32783
  21. Stephen A. Harrison, Peter J. Ruane, Bradley Freilich, Guy Neff, Rashmee Patil, Cynthia Behling, Chen Hu, Reshma Shringarpure, Brittany de Temple, Erica Fong, Erik J. Tillman, Timothy Rolph, Andrew Cheng, Kitty Yale. A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis. JHEP Reports 2023;5:100563
    https://doi.org/10.1016/j.jhepr.2022.100563
  22. Gong Feng, Yu Han, Wah Yang, Scott Shikora, Kamal Mahawar, Tan To Cheung, Giovanni Targher, Christopher D. Byrne, Virginia Hernandez-Gea, Herbert Tilg, Ming-Hua Zheng. Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery. Trends in Endocrinology & Metabolism 2024
    https://doi.org/10.1016/j.tem.2024.05.009
  23. Tae Seop Lim, Ho Soo Chun, Soon Sun Kim, Ja Kyung Kim, Minjong Lee, Hyo Jung Cho, Seung Up Kim, Jae Youn Cheong. Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes. Gut and Liver 2023;17:610
    https://doi.org/10.5009/gnl220400
  24. O.E. Abaturov, A.O. Nikulina. Metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: general provisions. CH 2024;19:107
    https://doi.org/10.22141/2224-0551.19.2.2024.1683
  25. Minsun Kwak, Hyun-seok Kim, Zhenghui Gordon Jiang, Yee Hui Yeo, Hirsh D. Trivedi, Mazen Noureddin, Ju Dong Yang. MASLD/MetALD and mortality in individuals with any cardio-metabolic risk factor: A population-based study with 26.7 years of follow-up. 2024
    https://doi.org/10.1097/HEP.0000000000000925
  26. Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A.A. Abdel-Ghany, Mohamed O. Mahmoud. From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences. Heliyon 2024;10:e30387
    https://doi.org/10.1016/j.heliyon.2024.e30387
  27. Xuemei Wang, Benchen Rao, Haiyu Wang, Zhenguo Liu, Shanshuo Liu, Suying Ding, Guizhen Zhang, Liwen Liu, Hongyan Ren, Chao Liu, Zhigang Ren, Zujiang Yu. Serum Metabolome Alterations in Patients With Nonalcoholic Fatty Liver Disease. SSRN Journal 2021
    https://doi.org/10.2139/ssrn.3969262
  28. Aamir Bashir, Ajay Duseja, Arka De, Manu Mehta, Pramil Tiwari. Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena. Liver Research 2022;6:72
    https://doi.org/10.1016/j.livres.2022.05.002
  29. Richie Manikat, Aijaz Ahmed, Donghee Kim. Current epidemiology of chronic liver disease. 2023;12
    https://doi.org/10.1093/gastro/goae069
  30. Hamed Kord-Varkaneh, Ammar Salehi-Sahlabadi, Grant M. Tinsley, Heitor O. Santos, Azita Hekmatdoost. Effects of time-restricted feeding (16/8) combined with a low-sugar diet on the management of non-alcoholic fatty liver disease: A randomized controlled trial. Nutrition 2023;105:111847
    https://doi.org/10.1016/j.nut.2022.111847
  31. Bianca M. Leca, Lukasz Lagojda, Chris Kite, Emmanouil Karteris, Eva Kassi, Harpal S. Randeva, Ioannis Kyrou. Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review. Expert Review of Endocrinology & Metabolism 2024;19:335
    https://doi.org/10.1080/17446651.2024.2365791
  32. V. N. Najafova. DIAGNOSTIC SIGNIFICANCE OF VARIOUS RADIOLOGICAL METHODS IN THE DETECTION OF PATHOLOGICAL CHANGES IN THE LIVER AGAINST OF BACKGROUND OF DIABETES MELLITUS. WOMAB 2023;19:115
    https://doi.org/10.26724/2079-8334-2023-2-84-115-118
  33. Florian Koutny, Dagobert Wiemann, Alexander Eckert, Svenja Meyhöfer, Maria Fritsch, Angeliki Pappa, Susanna Wiegand, Marc Weyer, Michael Wurm, Daniel Weghuber, Reinhard W. Holl. Poorly controlled pediatric type 1 diabetes mellitus is a risk factor for metabolic dysfunction associated steatotic liver disease (MASLD): An observational study. J. pediatr. gastroenterol. nutr. 2024;78:1027
    https://doi.org/10.1002/jpn3.12194
  34. Youn Huh, Yoon Jeong Cho, Ga Eun Nam. Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease. Journal of Obesity & Metabolic Syndrome 2022;31:17
    https://doi.org/10.7570/jomes22021
  35. Kaitlyn G. Jackson, Grayson W. Way, Jing Zeng, Marissa K. Lipp, Huiping Zhou. The Dynamic Role of Endoplasmic Reticulum Stress in Chronic Liver Disease. The American Journal of Pathology 2023;193:1389
    https://doi.org/10.1016/j.ajpath.2023.03.009
  36. Syed Ali Faran, Tanveer Hussain, Syed Haroon Khalid, Ikram Ullah Khan, Muhammad Asif, Junaid Ahmad, Abdul Rehman, Sajid Asghar. Bile acid/fatty acid integrated nanoemulsomes for nonalcoholic fatty liver targeted lovastatin delivery: stability, in-vitro, ex-vivo , and in-vivo analyses . Expert Opinion on Drug Delivery 2024;21:779
    https://doi.org/10.1080/17425247.2024.2361117
  37. Sue Shea, Christos Lionis, Chris Kite, Lou Atkinson, Surinderjeet S. Chaggar, Harpal S. Randeva, Ioannis Kyrou. Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress. Biomedicines 2021;9:1697
    https://doi.org/10.3390/biomedicines9111697
  38. Kaitlyn G. Jackson, Grayson W. Way, Huiping Zhou. Bile acids and sphingolipids in non-alcoholic fatty liver disease. 2022;135:1163
    https://doi.org/10.1097/CM9.0000000000002156
  39. Zheng Yao, Jia Guo, Bing Du, Li Hong, Ying Zhu, Xiaoyi Feng, Yuanlu Hou, Anhua Shi. Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice. Front. Microbiol. 2023;14
    https://doi.org/10.3389/fmicb.2023.1147067
  40. Naveeda Nawaz, Saba Arif, Rehan Anwar, Adnan Riaz, Asima Ayyub, Rafia Javed. Association of Adiponectin and Oxidized HDL with ABO Blood Groups in Fatty Liver Patients. PJHS 2024:79
    https://doi.org/10.54393/pjhs.v5i07.1847
  41. Rui Li, Ming Li, Alyce D. Fly, Aurelian Bidulescu, Juhua Luo. Vegetarian diets and risk of nonalcoholic fatty liver disease: An observational study of National Health and Nutrition Examination Survey 2005–2018 using propensity score methods. J Human Nutrition Diet 2024;37:643
    https://doi.org/10.1111/jhn.13290
  42. Sue Shea, Christos Lionis, Chris Kite, Lukasz Lagojda, Olalekan A. Uthman, Alexander Dallaway, Lou Atkinson, Surinderjeet S. Chaggar, Harpal S. Randeva, Ioannis Kyrou. Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis. Front. Endocrinol. 2024;15
    https://doi.org/10.3389/fendo.2024.1357664
  43. Zhiyong He, Yangyang Bin, Guangshun Chen, Qiang Li, Wenling Fan, Yongqiang Ma, Junfang Yi, Xiaohua Luo, Zhi Tan, Jiequn Li. Identification of MAP3K4 as a novel regulation factor of hepatic lipid metabolism in non-alcoholic fatty liver disease. J Transl Med 2022;20
    https://doi.org/10.1186/s12967-022-03734-8
  44. Mădălina Iuliana Mușat, Smaranda Ioana Mitran, Ion Udriștoiu, Carmen Valeria Albu, Bogdan Cătălin. The impact of stress on the behavior of C57BL/6 mice with liver injury: a comparative study. Front. Behav. Neurosci. 2024;18
    https://doi.org/10.3389/fnbeh.2024.1358964
  45. Xi Zhou, Li Yu, Min Zhou, Pengfei Hou, Long Yi, Mantian Mi. Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect. Nutr Metab (Lond) 2021;18
    https://doi.org/10.1186/s12986-021-00589-6
  46. Mohamad‐nabi Moradi, Hamid Behrouj, Behnam Alipoor, Nejat Kheiripour, Hadi Ghasemi, Hassan Ghasemi. Chlorella vulgaris is an effective supplement in counteracting non‐alcoholic fatty liver disease‐related complications through modulation of dyslipidemia, insulin resistance, and inflammatory pathways . J Food Biochem 2021;45
    https://doi.org/10.1111/jfbc.13914
  47. Nikoletta Maria Tagkou, Nicolas Goossens. Stéatose hépatique non alcoolique : diagnostic et traitement en 2022. Schweiz. Gastroenterol. 2023;4:27
    https://doi.org/10.1007/s43472-023-00091-9
  48. Donghee Kim, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed. Steatotic liver disease‐associated all‐cause/cause‐specific mortality in the United States. Aliment Pharmacol Ther 2024;60:33
    https://doi.org/10.1111/apt.18011
  49. Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Giorgia Litrico, Marcello Agosta, Gaetano La Greca, Saverio Latteri. Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-023-50190-5
  50. Chang-Yeon Kim, Namkyun Kim, Jae-Hyung Roh. Association of nonalcoholic fatty liver disease and venous thromboembolic disease in healthy adults in Korea: a nationwide study. Sci Rep 2023;13
    https://doi.org/10.1038/s41598-023-42963-9
  51. Harry D. Momo, Christian S. Alvarez, Mark P. Purdue, Barry I. Graubard, Katherine A. McGlynn. Associations of per- and polyfluoroalkyl substances and nonalcoholic fatty liver disease in the United States adult population, 2003–2018. 2024;8:e284
    https://doi.org/10.1097/EE9.0000000000000284
  52. Alok Raghav, Goo Bo Jeong. Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma. Cells 2024;13:638
    https://doi.org/10.3390/cells13070638
  53. Margalida Monserrat-Mesquida, Cristina Bouzas, Catalina M. Mascaró, Silvia Tejada, Antoni Sureda. Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD). Fermentation 2023;9:395
    https://doi.org/10.3390/fermentation9040395
  54. Eun Ju Cho, Goh Eun Chung, Jeong-Ju Yoo, Yuri Cho, Kyu Na Lee, Dong Wook Shin, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Su Jong Yu. Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups. Cardiovasc Diabetol 2024;23
    https://doi.org/10.1186/s12933-024-02408-7
  55. Min-Ji Kim, Min-Su Kim, Han-Byul Lee, Jae-Hyung Roh, Jae-Han Jeon. Relationship between the High Fatty Liver Index and Risk of Fracture. Gut and Liver 2023;17:119
    https://doi.org/10.5009/gnl210571
  56. Jeannette Widmer, Janina Eden, Fariba Abbassi, Roberta Angelico, Fabian Rössler, Beat Müllhaupt, Philipp Dutkowski, Marco Bueter, Andrea Schlegel. How best to combine liver transplantation and bariatric surgery?—Results from a global, web‐based survey. Liver International 2024;44:566
    https://doi.org/10.1111/liv.15791
  57. Reham Mohammed Dawood, Ghada Maher Salum, Mai Abd El-Meguid, Basma EL-sayed Fotouh. Molecular Insights of Nonalcoholic Fatty Liver Disease Pathogenesis. Journal of Interferon & Cytokine Research 2024;44:111
    https://doi.org/10.1089/jir.2023.0162
  58. Donghee Kim, Richie Manikat, Anjiya Shaikh, George Cholankeril, Aijaz Ahmed. Depression in nonalcoholic fatty liver disease and all‐cause/cause‐specific mortality. Eur J Clin Investigation 2024;54
    https://doi.org/10.1111/eci.14087
  59. Donghee Kim, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed. Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States. Journal of Hepatology 2024;80:e79
    https://doi.org/10.1016/j.jhep.2023.09.014
  60. Carlos Wustemberg Germano, Paulo Ferreira Mega, Thiago Jordão Almeida Prado Mattosinho, Luana Leite Castilho Dias, Martinho Antonio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Francisco Callejas-Neto, Elinton Adami Chaim, Everton Cazzo. Microvesicular Steatosis in Individuals with Obesity: a Histological Marker of Non-alcoholic Fatty Liver Disease Severity. OBES SURG 2023;33:813
    https://doi.org/10.1007/s11695-023-06467-9
  61. Hyejung Lee, Jae-Ho Lee. Homeostatic Model Assessment of Insulin Resistance as a Potential Screening Test for Non-Alcoholic Fatty Liver Disease in Korean Adults without Diabetes. Korean J Fam Pract 2023;13:233
    https://doi.org/10.21215/kjfp.2023.13.4.233
  62. Ji Won Kim, Tae Jun Kim, Ji Eun Kim, Ji Eun Na, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Poong-Lyul Rhee, Jae J Kim. Impact of Helicobacter pylori Eradication on the Risk of Incident Nonalcoholic Fatty Liver Disease: A Cohort Study. Korean J Helicobacter Up Gastrointest Res 2022;22:131
    https://doi.org/10.7704/kjhugr.2021.0060
  63. Hossein Farhadnejad, Asal Neshatbini Tehrani, Mitra Kazemi Jahromi, Farshad Teymoori, Ebrahim Mokhtari, Ammar Salehi-Sahlabadi, Parvin Mirmiran. The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults. BMC Gastroenterol 2022;22
    https://doi.org/10.1186/s12876-022-02353-3
  64. Nutan Sharma, Lakhwinder Singh, Aditya Sharma, Ajay Kumar, Dinesh Mahajan. NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors. Pharmacological Research 2024;208:107375
    https://doi.org/10.1016/j.phrs.2024.107375
  65. Juliana Silva Siqueira, Jessica Leite Garcia, Artur Junio Togneri Ferron, Fernando Moreto, Luis Eduardo Sormani, Mariane Rovero Costa, Thiago Luiz Novaga Palacio, Gisele Alborghetti Nai, Giancarlo Aldini, Fabiane Valentini Francisqueti-Ferron, Camila Renata Correa, Alfonsina D'Amato. Proteomic study of gamma-oryzanol preventive effect on a diet-induced non-alcoholic fatty liver disease model. The Journal of Nutritional Biochemistry 2024;127:109607
    https://doi.org/10.1016/j.jnutbio.2024.109607
  66. Asal Neshatbini Tehrani, Behzad Hatami, Ghazal Daftari, Azita Hekmatdoost, Zahra Yari, Amin Salehpour, Seyed Ahmad Hosseini, Bizhan Helli. The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial. BMC Public Health 2024;24
    https://doi.org/10.1186/s12889-024-18812-3
  67. Donghee Kim, Richie Manikat, George Cholankeril, Aijaz Ahmed. Endogenous sex hormones and nonalcoholic fatty liver disease in US adults. Liver International 2024;44:460
    https://doi.org/10.1111/liv.15786
  68. Mitra Kazemi Jahromi, Asal Neshatbini Tehrani, Farshad Teymoori, Ghazal Daftari, Hamid Ahmadirad, Niloufar Saber, Ammar Salehi-Sahlabadi, Hossein Farhadnejad, Parvin Mirmiran. Dietary advanced glycation end products are associated with an increased risk of non-alcoholic fatty liver disease in Iranian adults. BMC Endocr Disord 2023;23
    https://doi.org/10.1186/s12902-023-01365-8
  69. Peter Konyn, Omar Alshuwaykh, Brittany B. Dennis, George Cholankeril, Aijaz Ahmed, Donghee Kim. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality. Clinical Gastroenterology and Hepatology 2023;21:940
    https://doi.org/10.1016/j.cgh.2022.04.043
  70. Mohamed El-Kassas, Abeer Awad, Mohamed Elbadry, Juan Pablo Arab. Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Semin Liver Dis 2024;44:054
    https://doi.org/10.1055/a-2253-9181
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd